Manfred Schubert‐Zsilavecz

7.7k total citations
235 papers, 6.2k citations indexed

About

Manfred Schubert‐Zsilavecz is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Manfred Schubert‐Zsilavecz has authored 235 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 68 papers in Pharmacology and 49 papers in Organic Chemistry. Recurrent topics in Manfred Schubert‐Zsilavecz's work include Peroxisome Proliferator-Activated Receptors (41 papers), Inflammatory mediators and NSAID effects (25 papers) and Drug Transport and Resistance Mechanisms (19 papers). Manfred Schubert‐Zsilavecz is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (41 papers), Inflammatory mediators and NSAID effects (25 papers) and Drug Transport and Resistance Mechanisms (19 papers). Manfred Schubert‐Zsilavecz collaborates with scholars based in Germany, Austria and Switzerland. Manfred Schubert‐Zsilavecz's co-authors include Mario Wurglics, Mona Abdel‐Tawab, Oliver Werz, Michael Karas, Daniel Merk, Dieter Steinhilber, Oliver Rau, U. Bahr, Alexander Paulke and Heiko Zettl and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Analytical Chemistry.

In The Last Decade

Manfred Schubert‐Zsilavecz

228 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manfred Schubert‐Zsilavecz Germany 43 3.1k 1.6k 865 777 742 235 6.2k
Vaqar M. Adhami United States 62 4.4k 1.4× 1.7k 1.1× 1.2k 1.4× 573 0.7× 517 0.7× 122 10.3k
Xiaochi Ma China 43 3.8k 1.3× 1.3k 0.8× 851 1.0× 668 0.9× 1.5k 2.0× 360 8.2k
Daniela Schuster Austria 44 3.5k 1.1× 1.5k 0.9× 990 1.1× 980 1.3× 1.3k 1.7× 180 7.4k
Verena M. Dirsch Austria 45 4.0k 1.3× 1.0k 0.6× 1.9k 2.2× 679 0.9× 938 1.3× 172 8.7k
Lihong Hu China 47 4.2k 1.4× 1.1k 0.7× 1.2k 1.4× 2.2k 2.8× 754 1.0× 345 8.5k
Patrizia Hrelia Italy 42 3.1k 1.0× 835 0.5× 960 1.1× 968 1.2× 343 0.5× 242 6.5k
Won Keun Oh South Korea 45 4.5k 1.5× 1.2k 0.7× 1.3k 1.5× 642 0.8× 1.1k 1.5× 268 8.0k
Elke H. Heiß Austria 41 4.1k 1.3× 919 0.6× 1.6k 1.8× 711 0.9× 1.1k 1.5× 125 7.9k
Yao Chen China 41 2.1k 0.7× 1.2k 0.7× 523 0.6× 392 0.5× 930 1.3× 295 5.9k
Apichart Suksamrarn Thailand 42 2.9k 0.9× 998 0.6× 1.7k 1.9× 936 1.2× 889 1.2× 299 6.8k

Countries citing papers authored by Manfred Schubert‐Zsilavecz

Since Specialization
Citations

This map shows the geographic impact of Manfred Schubert‐Zsilavecz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manfred Schubert‐Zsilavecz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manfred Schubert‐Zsilavecz more than expected).

Fields of papers citing papers by Manfred Schubert‐Zsilavecz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manfred Schubert‐Zsilavecz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manfred Schubert‐Zsilavecz. The network helps show where Manfred Schubert‐Zsilavecz may publish in the future.

Co-authorship network of co-authors of Manfred Schubert‐Zsilavecz

This figure shows the co-authorship network connecting the top 25 collaborators of Manfred Schubert‐Zsilavecz. A scholar is included among the top collaborators of Manfred Schubert‐Zsilavecz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manfred Schubert‐Zsilavecz. Manfred Schubert‐Zsilavecz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berger, Lena M., Andreas Krämer, Astrid Kaiser, et al.. (2022). Discovery of 3-Amino-1H-pyrazole-Based Kinase Inhibitors to Illuminate the Understudied PCTAIRE Family. International Journal of Molecular Sciences. 23(23). 14834–14834. 5 indexed citations
2.
Schubert‐Zsilavecz, Manfred, et al.. (2020). Analysis of 4‐fluoroamphetamine in cerumen after controlled oral application. Drug Testing and Analysis. 12(7). 968–974. 5 indexed citations
3.
Heitel, Pascal, Jan Heering, Astrid S. Kahnt, et al.. (2018). Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro. Scientific Reports. 8(1). 13554–13554. 14 indexed citations
4.
Werner, Markus, Lucia Esposito, Fabiana Troisi, et al.. (2018). Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase that favorably modulates lipid mediator biosynthesis in inflammation. European Journal of Medicinal Chemistry. 156. 815–830. 15 indexed citations
5.
Merk, Daniel, Dieter Steinhilber, & Manfred Schubert‐Zsilavecz. (2013). Characterizing ligands for farnesoid X receptor – availablein vitrotest systems for farnesoid X receptor modulator development. Expert Opinion on Drug Discovery. 9(1). 27–37. 14 indexed citations
6.
Merk, Daniel & Manfred Schubert‐Zsilavecz. (2013). Repairing mutated proteins – development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator. Expert Opinion on Drug Discovery. 8(6). 691–708. 10 indexed citations
7.
Fuhr, Uwe, et al.. (2012). Study on the Dosing Accuracy of Commonly Used Disposable Insulin Pens. Diabetes Technology & Therapeutics. 14(9). 804–809. 24 indexed citations
8.
Paulke, Alexander, et al.. (2012). Isoquercitrin provides better bioavailability than quercetin: comparison of quercetin metabolites in body tissue and brain sections after six days administration of isoquercitrin and quercetin.. PubMed. 67(12). 991–6. 45 indexed citations
9.
Hahn, Steffen, Franca‐Maria Klingler, Jan Heering, et al.. (2011). Complementary Screening Techniques Yielded Fragments that Inhibit the Phosphatase Activity of Soluble Epoxide Hydrolase. ChemMedChem. 6(12). 2146–2149. 11 indexed citations
10.
Proschak, Ewgenij, et al.. (2010). Rational design of a pirinixic acid derivative that acts as subtype-selective PPARγ modulator. Bioorganic & Medicinal Chemistry Letters. 20(8). 2469–2473. 9 indexed citations
11.
Zettl, Heiko, Manfred Schubert‐Zsilavecz, & Dieter Steinhilber. (2009). Medicinal Chemistry of Incretin Mimetics and DPP‐4 Inhibitors. ChemMedChem. 5(2). 179–185. 30 indexed citations
12.
Zettl, Heiko, et al.. (2009). Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARα agonists. Bioorganic & Medicinal Chemistry Letters. 19(15). 4421–4426. 18 indexed citations
13.
Koeberle, Andreas, Antonietta Rossi, Heiko Zettl, et al.. (2009). The Molecular Pharmacology and In Vivo Activity of 2-(4-Chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a Dual Inhibitor of Microsomal Prostaglandin E2 Synthase-1 and 5-Lipoxygenase. Journal of Pharmacology and Experimental Therapeutics. 332(3). 840–848. 43 indexed citations
14.
Zettl, Heiko, Ewgenij Proschak, Oliver Rau, et al.. (2009). Novel Pirinixic Acids as PPARα Preferential Dual PPARα/γ Agonists. QSAR & Combinatorial Science. 28(5). 576–586. 11 indexed citations
15.
Schubert‐Zsilavecz, Manfred & Theo Dingermann. (2008). Stellungnahme zum Referentenentwurf des Gesetzes über genetische Untersuchungen bei Menschen (Gendiagnostikgesetz, GenDG). Pharmazie in unserer Zeit. 37(5). 425–425. 2 indexed citations
16.
Daneshfar, Rambod, Gunter P. Eckert, Jochen Klein, et al.. (2008). Metabolism of Boswellic Acids in Vitro and in Vivo. Drug Metabolism and Disposition. 36(6). 1135–1142. 101 indexed citations
17.
Paulke, Alexander, Michael Nöldner, Manfred Schubert‐Zsilavecz, & Mario Wurglics. (2008). St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses.. PubMed. 63(4). 296–302. 39 indexed citations
18.
Paulke, Alexander, Manfred Schubert‐Zsilavecz, & Mario Wurglics. (2006). Determination of St. John's wort flavonoid-metabolites in rat brain through high performance liquid chromatography coupled with fluorescence detection. Journal of Chromatography B. 832(1). 109–113. 79 indexed citations
19.
Wurglics, Mario, et al.. (2005). Geschichte der Ulcustherapie: Ein historischer Rückblick. Pharmazie in unserer Zeit. 34(3). 188–192. 1 indexed citations
20.
Bučar, Franz, Sanjay M. Jachak, Theodor Kartnig, & Manfred Schubert‐Zsilavecz. (1998). PHENOLIC COMPOUNDS FROM BIOPHYTUM SENSITIVUM. Pharmazie. 53(9). 651–653. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vaqar M. Adhami Breakdown of academic impact, for papers by Xiaochi Ma Breakdown of academic impact, for papers by Daniela Schuster Breakdown of academic impact, for papers by Verena M. Dirsch Breakdown of academic impact, for papers by Lihong Hu Breakdown of academic impact, for papers by Patrizia Hrelia Breakdown of academic impact, for papers by Won Keun Oh Breakdown of academic impact, for papers by Elke H. Heiß Breakdown of academic impact, for papers by Yao Chen Breakdown of academic impact, for papers by Apichart Suksamrarn
Rankless by CCL
2026